BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2026 7:34:00 AM | Browse: 1 | Download: 0
 |
Received |
|
2025-11-10 04:51 |
|
Peer-Review Started |
|
2025-11-10 05:43 |
|
First Decision by Editorial Office Director |
|
2025-12-11 09:50 |
|
Return for Revision |
|
2025-12-11 09:50 |
|
Revised |
|
2025-12-23 05:32 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-01-15 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-15 03:21 |
|
Articles in Press |
|
2026-01-15 03:21 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-03-03 03:53 |
|
Publish the Manuscript Online |
|
2026-07-14 07:34 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
IGF2BP3 in gastric cancer: Unraveling an m⁶A-driven oncogenic axis for therapeutic targeting
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Qi-Yuan Feng, Si-Bi Yin, Ling-Yun Luo, Li-Yang Dai and Xue-Lian Luo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xue-Lian Luo, Department of Oncology, The Third Affiliated Hospital of Chongqing Medical University, Huixing Street, Yubei District, Chongqing 401120, China. 806850653@qq.com |
| Key Words |
Gastric cancer; N6-methyladenosine; IGF2BP3; FBXO32; Cyclic guanosine monophosphate-protein kinase G pathway; Therapeutic target |
| Core Tip |
The insulin-like growth factor 2 mRNA-binding protein 3(IGF2BP3)/ F-box protein 32(FBXO32)/ cyclic guanosine monophosphate-protein kinase G (cGMP-PKG) axis represents a novel N⁶-methyladenosine(m⁶A)-driven pathway in gastric cancer progression. Targeting this axis may offer a new therapeutic strategy, particularly for aggressive subtypes characterized by high IGF2BP3 expression. |
| Publish Date |
2026-07-14 07:34 |
| Citation |
Feng QY, Yin SB, Luo LY, Dai LY, Luo XL. IGF2BP3 in gastric cancer: Unraveling an m⁶A-driven oncogenic axis for therapeutic targeting. World J Gastroenterol 2026; 32(27): 116347
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i27/116347.htm |
| DOI |
https://doi.org/10.3748/wjg.116347 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
